Reported net income was $2 million for the first quarter, up from $1.2 million last year. The company attributes its success to its direct sports medicine and BGS/GO implants. The company is investing in new product development initiatives and direct distribution this year, which could positively impact future revenue growth.
More Articles on Orthopedic Device Companies:
AlloSource Hires Dale Binke as Vice President of Marketing & Sales
Orthofix Sells Sports Medicine Business for $157.5M
Johnson & Johnson Q1 Orthopedic Sales Flat
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.